AssetMark Inc’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$342K Buy
12,917
+2
+0% +$53 ﹤0.01% 1109
2025
Q1
$312K Buy
12,915
+789
+7% +$19.1K ﹤0.01% 1063
2024
Q4
$488K Buy
12,126
+1,637
+16% +$65.9K ﹤0.01% 961
2024
Q3
$664K Buy
10,489
+9,198
+712% +$582K ﹤0.01% 851
2024
Q2
$68.4K Buy
1,291
+528
+69% +$28K ﹤0.01% 1174
2024
Q1
$62.6K Buy
+763
New +$62.6K ﹤0.01% 1123